Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Valeria L. Orlova"'
Autor:
Maria V Verbovaya, Ivan S Lunev, Anna A Mosikian, Bella R Zinnatulina, Alexandr Y Mayorov, Diana N Alpenidze, Igor E. Makarenko, Roman V. Drai, Alexander L Khokhlov, Valeria L Orlova
Publikováno v:
Journal of Comparative Effectiveness Research. 10:55-66
Aim: To compare safety (immunogenicity) and efficacy of a biosimilar insulin GP-Lis25 and a reference insulin Ly-Lis25 (Humalog Mix 25) in Type 2 diabetes mellitus (T2D) patients. Materials & methods: This randomized open-label, 26-week clinical tria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::906c65ee64499c9830107b39960acf29
https://doi.org/10.2217/cer-2020-0064
https://doi.org/10.2217/cer-2020-0064
Autor:
Wim Wilpshaar, Valeria L. Orlova, Andrey F. Verbovoy, Reiner Tretter, Marina Vladimirovna Shestakova, John P.H. Wilding
Publikováno v:
DIABETES RESEARCH AND CLINICAL PRACTICE
To assess the efficacy and safety of ipragliflozin as add-on therapy to metformin in Russian patients with type 2 diabetes mellitus.In this double-blind study conducted in 14 centers in Russia, 165 patients were randomized 2:1 to ipragliflozin (50 mg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::319d9150432b13a35829fefc6458414d
https://doi.org/10.1016/j.diabres.2018.10.018
https://doi.org/10.1016/j.diabres.2018.10.018
Autor:
Reiner Tretter, Wim Wilpshaar, Andrey F. Verbovoy, Valeria L. Orlova, Marina Vladimirovna Shestakova, John P.H. Wilding
Publikováno v:
Diabetes. 67
Aim: To assess the efficacy and safety of ipragliflozin as add-on therapy to metformin in Russian patients with T2DM. Methods: In this double-blind trial conducted in 14 centers in Russia, 165 patients were randomized 2:1 to ipragliflozin (50 mg/day)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ee76cc7ed85178d1edbdf849ad8a40d
https://doi.org/10.2337/db18-1131-p
https://doi.org/10.2337/db18-1131-p